tirzepatide to retatrutide conversion Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are RETATRUTIDE: A Medication for Diabetes

By targeting metabolic pathways, the peptide may reduce liver fat accumulation and improve liver function, addressing a condition that often accompanies obesity and diabetes

In addition, stable lean mass was observed with both GLP-1 RA monotherapy and combination, with greater fat-mass loss in combination

GEORGE FREY/BLOOMBERG VIA GETTY IMAGES Es difcil encender el televisor, leer las noticias o mantener una conversacin sin escuchar sobre Ozempic y otros medicamentos similares que pertenecen a una clase de medicamentos conocidos como agonistas del receptor pptido 1 similar al glucagn (GLP-1)

Our expert team of healthcare professionals will work with you to create a customized weight loss plan tailored to your unique needs and goals